Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

 

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update
J

Systemic Therapeutic Options in Advanced Thyroid Cancer: BRAF Mutations Are Not Uncommon and Offer Additional Therapeutic Target

By Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update FEATURING Jessica Geiger
By Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update FEATURING Jessica Geiger
117 views
March 18, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Larynx/Thyroid
24:28

Surgical Management of Laryngeal Papilloma

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

M. Benninger

23 views
18:59

Can We Preserve Larynx in T4 Laryngeal Cancer?

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

D. Adelstein

174 views
23:51

The Role of EBRT for Advanced Thyroid Malignancies: Multidisciplinar…

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

N. Joshi

25 views
21:36

Systemic Therapeutic Options in Advanced Thyroid Cancer: BRAF Mutati…

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

J. Geiger

117 views
08:08

Ongoing Clinical Trials in Advanced Thyroid Cancer: RET Inhibitors (…

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

J. Geiger

131 views
25:55

Case Based Discussion Panel on Larynx/Thyroid Cancer: Surgical Manag…

Cleveland Clinic's 2020 Multidisciplinary Head and Neck Cancer Update

J. Scharpf, J. Geiger, N. Joshi, B. Burkey

34 views